• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY ORBERA365 INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY ORBERA365 INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Model Number B-50012
Device Problems Burst Container or Vessel (1074); Deflation Problem (1149); Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/20/2023
Event Type  Injury  
Manufacturer Narrative
Block h6 imdrf f2202: captures the reportable event of additional endoscopic procedure.Imdf a0402: captures the reportable event of balloon burst.
 
Event Description
It was reported to boston scientific corporation that an orbera365 intragastric balloon system was used on an intragastric balloon placement procedure used to treat obesity performed on (b)(6) 2023.After 7 months of having the balloon placed, the patient noticed having blue urine on (b)(6) 2023.A balloon rupture is presumed, and an endoscopic procedure was performed to confirm the malfunction.Note: it was reported that methylene blue was used when filling the orbera balloon.However, according to the instructions for use (ifu) the igb is placed in the stomach and filled with sterile saline.
 
Manufacturer Narrative
Block h6 imdrf f2202: captures the reportable event of additional endoscopic procedure.Imdf a0402: captures the reportable event of balloon burst.Correction: block h6 device code has been corrected to device code.A1401 deflation problem, which is also reportable.
 
Event Description
It was reported to boston scientific corporation that an orbera 365 intragastric balloon system was used on an intragastric balloon placement procedure used to treat obesity performed on (b)(6) 2023.After 7 months of having the balloon placed, the patient noticed having blue urine on (b)(6) 2023.A balloon rupture is presumed and an endoscopic revision was also performed on (b)(6) 2023 which confirmed the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA365 INTRAGASTRIC BALLOON SYSTEM
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. capital of texas hwy
bldg 1 suite 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA
alajuela
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18702044
MDR Text Key335349080
Report Number3005099803-2024-00499
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeCO
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/14/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberB-50012
Device Lot NumberAF05275
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
Patient SexMale
Patient Weight102 KG
-
-